NCT03427593View on ClinicalTrials.gov

Severe PID With Lymphoproliferation and Neutropenia

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

March 13, 2018

Primary Completion Date

March 13, 2018

Study Completion Date

December 5, 2019

Conditions
Primary Immune-Deficiency (PID) Common Variable Immune Deficiency (CVID)
Interventions
GENETIC

FACS analyses

FACS analyses

GENETIC

Target Sequencing by NGS ( Next-generation sequencing)

Target Sequencing by NGS ( Next-generation sequencing)

GENETIC

Whole Exome Sequencing

Whole Exome Sequencing

Trial Locations (1)

67091

Service d'Immunologie Clinique et VIH - Hôpital Civil, Strasbourg

All Listed Sponsors
lead

University Hospital, Strasbourg, France

OTHER

NCT03427593 - Severe PID With Lymphoproliferation and Neutropenia | Biotech Hunter | Biotech Hunter